Open AccessThe main will of the patients of a private Italian IVF clinic for their aneuploid/affected blastocysts would be donation to research: a currently forbidden choice
Author(s) -
Federica Faustini,
Marina Forte,
Antonio Capalbo,
Danilo Cimadomo,
Filippo Maria Ubaldi,
Laura Rienzi
Publication year - 2019
Publication title -
journal of assisted reproduction and genetics
Language(s) - English
Resource type - Journals
eISSN - 1573-7330
pISSN - 1058-0468
DOI - 10.1007/s10815-019-01465-2
Subject(s) - cryopreservation , donation , reproductive medicine , embryo transfer , in vitro fertilisation , infertility , embryo donation , gynecology , egg donation , embryo , embryo cryopreservation , aneuploidy , genetic testing , medicine , biology , pregnancy , andrology , genetics , economics , gene , chromosome , economic growth
Surplus cryopreserved affected/aneuploid blastocysts may be obtained after in vitro fertilization (IVF) treatments with preimplantation genetic testing (PGT). These embryos are considered not suitable for transfer and may be discarded. Currently, in Italy, an embryo disposition decision (EDD) is not allowed and the frozen/vitrified blastocysts (even if affected/aneuploid) should be kept cryopreserved indefinitely. In this peculiar clinical, social, and legislative scenario, we aimed at assessing the attitudes of the patients towards the fate of these embryos, in case the local regulation would be changed and allow an EDD regarding the surplus affected/aneuploid embryos obtained after PGT.